OpGen (OPGN) Announced 1-for-20 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
OpGen Announced 1-for-20 Reverse Stock Split
January 4, 2023 4:30 PM ESTROCKVILLE, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, OpGen or the Company), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that the Companys board of directors has approved a 1-for-20 reverse stock split of its shares of common stock (the Reverse Stock Split). The Reverse Stock Split will become effective at 12:01 a.m. EST, on January 5, 2023 and the Companys common stock will open for trading on The Nasdaq Capital Market on a post-split basis under the Companys existing trading symbol OPGN. The new CUSIP number for... More



